Keurig Dr Pepper, Inc $KDP Shares Sold by Ilmarinen Mutual Pension Insurance Co

Key Points

• Ilmarinen Mutual Pension Insurance Co reduced its holdings in Keurig Dr Pepper by 8.6%, taking ownership down to 370,000 shares worth approximately $12.66 million.
• Keurig Dr Pepper reported $4.16 billion in revenue for the last quarter, slightly above analysts' expectations, and its earnings per share matched the consensus estimate at $0.49.
• Several analysts have updated their price targets for Keurig Dr Pepper, with the average target currently set at $38.38 following various ratings including multiple "buy" ratings.

Ilmarinen Mutual Pension Insurance Co lessened its stake in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 8.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 370,000 shares of the company's stock after selling 35,000 shares during the quarter. Ilmarinen Mutual Pension Insurance Co's holdings in Keurig Dr Pepper were worth $12,661,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in KDP. Rise Advisors LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter valued at about $25,000. ST Germain D J Co. Inc. acquired a new stake in shares of Keurig Dr Pepper during the 1st quarter worth about $27,000. WPG Advisers LLC purchased a new stake in Keurig Dr Pepper during the first quarter worth approximately $43,000. Continuum Advisory LLC lifted its stake in Keurig Dr Pepper by 82.5% during the first quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock worth $46,000 after purchasing an additional 602 shares during the last quarter. Finally, Global Trust Asset Management LLC purchased a new stake in Keurig Dr Pepper during the first quarter worth approximately $48,000. Hedge funds and other institutional investors own 93.99% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on KDP. Barclays boosted their target price on Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research note on Monday, July 28th. UBS Group decreased their target price on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a research note on Wednesday, August 27th. Deutsche Bank Aktiengesellschaft decreased their target price on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research note on Tuesday, August 26th. Hsbc Global Res cut Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 26th. Finally, JPMorgan Chase & Co. decreased their target price on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a research note on Thursday, July 17th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $38.38.

Keurig Dr Pepper Stock Performance

KDP traded down $0.36 during trading on Friday, hitting $27.23. 15,131,594 shares of the stock were exchanged, compared to its average volume of 22,052,268. The firm has a market capitalization of $36.99 billion, a P/E ratio of 24.31, a PEG ratio of 1.51 and a beta of 0.47. Keurig Dr Pepper, Inc has a 1-year low of $27.01 and a 1-year high of $38.28. The stock has a fifty day moving average price of $32.35 and a two-hundred day moving average price of $33.27. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting the consensus estimate of $0.49. The company had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The firm's revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 earnings per share. As a group, sell-side analysts predict that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.

Insider Activity at Keurig Dr Pepper

In other news, insider Mary Beth Denooyer sold 12,000 shares of the business's stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the transaction, the insider owned 82,511 shares of the company's stock, valued at approximately $2,777,320.26. The trade was a 12.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Robert James Gamgort sold 208,000 shares of the business's stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $32.90, for a total value of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares in the company, valued at approximately $75,412,360.10. The trade was a 8.32% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 459,601 shares of company stock worth $15,228,872. 0.40% of the stock is currently owned by corporate insiders.

Keurig Dr Pepper Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.